comparemela.com

Latest Breaking News On - Phepatology communications - Page 5 : comparemela.com

Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy

Lower treatment retention rates seen with 30-day, out-of-pocket costs $150 or greater.

University of minnesotaPhepatology communicationsHealthday news

Expensive Treatment Associated With Low Retention Rates Among Patients With Hepatic Encephalopathy

Investigators highlighted an association between treatment retention over time and the out-of-pocket cost for patients with hepatic encephalopathy taking rifaximin.

United statesAmerican liver foundationUniversity of minnesota medical schoolM health fairview elizabeth abyM health fairviewPhepatology communicationsElizabeth abyMinnesota medical schoolScan commercial claimsEncounters databaseTreating hepaticAccessed augustMinnesota medicalHepatic encephalopathyTreatment retention

Research: Study finds how high drug price linked with decreased treatment retention for chronic liver disease patients, ET HealthWorld

Research: The findings of the study were recently published in Hepatology Communications. The loss of brain function that occurs in persons with severe liver illness is known as hepatic encephalopathy. High morbidity and mortality rates are linked to the disorder. Rifaximin is a medication that is frequently used to treat hepatic encephalopathy, however, treatment adherence is still low.

United statesCollege of pharmacyM health fairviewPhepatology communicationsUniversity of minnesota medical schoolMinnesota medical schoolElizabeth abyElizabeth abyUniversity of minnesota medical schoolLiver diseaseHealth news

Study finds how high drug price linked with decreased treatment retention for chronic liver disease patients

Study finds how high drug price linked with decreased treatment retention for chronic liver disease patients
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesPhepatology communicationsCollege of pharmacyUniversity of minnesota medical schoolM health fairviewMinnesota medical schoolElizabeth aby

High cost of hepatic encephalopathy treatment may lead to medication non-adherence

Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease were associated with decreased treatment retention for patients.

United statesDanielle ellisCollege of pharmacyM health fairviewPhepatology communicationsUniversity of minnesota medical schoolMinnesota medical schoolAssistant professorLiver diseaseHepatic encephalopathyMedical school

vimarsana © 2020. All Rights Reserved.